Coverage
-
September 19, 2023
COVID-19 testing company Lucira Health Inc. received approval Tuesday from a Delaware bankruptcy judge to liquidate its remaining assets in Chapter 11 after the company struck a $36.4 million deal in April to sell its business to Pfizer Inc.
3 other articles on this case.
View all »